Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes. (Q34493789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Nicolas Rocher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Francine Behar-Cohen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jean-Antoine C Pournaras

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Marie-Christine Naud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jean-Claude Jeanny

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Laurent Jonet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

11 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

104-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

Perilimbal Bevacizumab Injection for Interface Neovascularization After Deep Anterior Lamellar Keratoplasty

20 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Vascular endothelial growth factor in eye disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Immune mechanisms of corneal allograft rejection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Biopharmaceutical considerations in topical ocular drug delivery

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

The behaviour of ED1- and ED2-positive cells in the rat iris and choroid following penetrating keratoplasty and cyclosporin A therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Drop Size and Initial Dosing Frequency Problems of Topically Applied Ophthalmic Drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Corneal graft surgery combined with subconjunctival bevacizumab (avastin).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Safety profile of topical VEGF neutralization at the cornea

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Epidemiology and risk factors for corneal graft rejection

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Influence of format on in vitro penetration of antibody fragments through porcine cornea

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Risk factors for various causes of failure in initial corneal grafts

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Penetration of engineered antibody fragments into the eye.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Promotion of Graft Survival by Vascular Endothelial Growth Factor A Neutralization After High-Risk Corneal Transplantation

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021565

Avastin use in high risk corneal transplantation

9 December 2018

1 reference

12 December 2020

Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas

1 reference

12 December 2020

Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose

1 reference

12 December 2020

Corneal epithelial rejection in the rat

1 reference

12 December 2020

Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy

1 reference

12 December 2020

Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model

1 reference

12 December 2020

Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group

1 reference

12 December 2020

Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction

1 reference

12 December 2020

Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization

1 reference

12 December 2020

Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis

1 reference

12 December 2020

Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles

1 reference

12 December 2020

Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats

1 reference

12 December 2020

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis

1 reference

12 December 2020

Nitrosative stress and corneal transplant endothelial cell death during acute graft rejection

1 reference

12 December 2020

Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis

1 reference

12 December 2020

Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome

1 reference

12 December 2020

Subconjunctival bevacizumab for corneal neovascularization

1 reference

12 December 2020

Bevacizumab (avastin) for corneal neovascularization--corneal light shield soaked application

1 reference

12 December 2020

Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245949%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

21245949

1 reference